About NKGen Biotech NKGen is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic NK cell therapeutics. NKGen is ...

NKGen Biotech, Inc. (OTC: NKGN) ("NKGen" or the "Company"), a clinical-stage biotechnology company focused on the development and commercialization ...

Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, releases the following letter to ...

Noticing six changes to how you walk could be a warning sign as young onset dementia, with the condition impacting people as ...

The mother of a young man who died of dementia has bravely opened up on her son's diagnosis, including the first time she noticed something wasn't quite right. Andre Yarham, who lived in Dereham, ...

In evaluable patients, IMC002 achieved an objective response rate (ORR) of 66.7% (10/15). Survival data were immature at the time of analysis, with a median progression-free survival (mPFS) of 7.0 ...

AbbVie will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026. Management will participate in a fireside chat at 10:15 a.m. Central time. A live audio webcast ...

Andre Yarham of Norfolk, England, was among the youngest people in the U.K. to die from this rare form of dementia.

Detailed price information for Voyager Therapeut (VYGR-Q) from The Globe and Mail including charting and trades.

Andre Yarham's frontotemporal dementia diagnosis at the age of 22 came after his family started noticing differences in his ...

Every day, millions of people use Shopify to power their businesses. From online side hustles to global retail giants, ...

Entain will bring some of the best casinos on the internet in britain leading them to a given complement our very own local casino ideal listing. Erik ...